share_log

Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) Estimate

Moomoo 24/7 ·  Mar 26 09:28

Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment